Safety reporting in Hong Kong

Pharmacovigilance (PV)

This topic has 0 replies, 1 voice, and was last updated 1 year, 8 months ago by Mrs Kelly Gee.

Viewing 1 post (of 1 total)

Author

Posts
17 August 2022 at 4:14 pm #5507

Does anyone have any knowledge or experience of the requirements for safety reporting for an IMP trial looking to open a site in Hong Kong?
Author

Posts

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.

MRC-NIHR Trials Methodology Research Partnership

Get in touch

If you have any questions about the site, please feel free to contact us. We are always looking for ways to better serve our members - YOU are important to us!

(0113) 3439132